![James Nisco](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermogen: 37 573 $ op 31-05-2026
James Nisco currently works at Lisata Therapeutics, Inc., as Chief Accounting Officer, SVP-Finance & Treasury from 2024.
Mr. Nisco also formerly worked at Caladrius Biosciences, Inc., as Vice President-Finance & Treasury.
Mr. Nisco received his undergraduate degree from State University of New York College at Oneonta and Masters Business Admin degree from Pace University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 09-01-2026 | 11.561 ( 0,13% ) | 37 573 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| LISATA THERAPEUTICS, INC. | Financieel Directeur/CFO | 01-08-2020 |
| Bedrijven | Functie | Einde |
|---|---|---|
Caladrius Biosciences, Inc.
 Caladrius Biosciences, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes cellular therapies products | Financieel Directeur/CFO | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 4 |
|---|---|
State University of New York College at Oneonta
 State University of New York College at Oneonta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pace University
 Pace University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes cellular therapies products | Health Technology |
Lisata Therapeutics, Inc.
 Lisata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
